Latest News in the pharma Industry

Top Stories

Rheumatoid arthritis clinical trial to continue

Rheumatoid arthritis clinical trial to continue

8 Mar 2013

Drug formulation PRTX-100 passed a scheduled interim data safety monitoring committee meeting.

Read more 
OncoMed begins Phase 1 clinical trial of stem cell drug

OncoMed begins Phase 1 clinical trial of stem cell drug

8 Mar 2013

OMP-52M51 is a therapeutic that targets cancer stem cells.

Read more 
Immune system-enhancing drug could beat colorectal cancer

Immune system-enhancing drug could beat colorectal cancer

7 Mar 2013

Tests involving the delivery of an immune system-enhancing drug to patients suffering from colorectal cancer have shown promise.

Read more 
Abbott completes separation into two independent companies

Abbott completes separation into two independent companies

1 Mar 2013

A new independent company called AbbVie has been formed to take forward Abbott's research-based pharmaceuticals business.

Read more 
Saudi Arabia pharma market to reach $4.7bn by 2016

Saudi Arabia pharma market to reach $4.7bn by 2016

1 Mar 2013

Saudi Arabia is one of the largest pharmaceutical markets in the Middle East and is due to experience steady growth.

Read more 
Novartis names Dr Joerg Reinhardt as new chairman

Novartis names Dr Joerg Reinhardt as new chairman

27 Feb 2013

Dr Joerg Reinhardt will be the new chairman of Novartis, succeeding Dr Daniel Vasella.

Read more 
OvaSciences announced 2012 financial results

OvaSciences announced 2012 financial results

25 Feb 2013

OvaSciences enjoyed a strong year with most of its R&D spend coming on CROs for a major new trial.

Read more 
Ligand receives milestone payment in development of RE-021

Ligand receives milestone payment in development of RE-021

25 Feb 2013

Development of the clinical candidate RE-021 is being handled by Retrophin, which also has commercialisation rights.

Read more 
Digital Pharma Experience set for Prague

Digital Pharma Experience set for Prague

20 Feb 2013

The Digital Pharma Experience takes place in Prague in May.

Read more 
Diagnovus designs assay for DLBCL

Diagnovus designs assay for DLBCL

20 Feb 2013

Diagnovus' new gene expression assay aims to provide more accurate risk profiles for DLBCL patients.

Read more 
Roche to commercialise Chiasma’s Octreolin treatment

Roche to commercialise Chiasma’s Octreolin treatment

19 Feb 2013

Roche has acquired global licencing rights for the acromegaly treatment, which is in phase three trials.

Read more 
Almac and DSM Pharma sharing enzyme expertise

Almac and DSM Pharma sharing enzyme expertise

19 Feb 2013

The two firms are collaborating to improve their green performance and enzyme process development.

Read more